GALECTIN THERAPEUTICS INC — Director's Dealing 2013

Oct 18, 2013

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: GALECTIN THERAPEUTICS INC (GALT)
CIK: 0001133416
Period of Report: 2013-10-16

Reporting Person: CZIRR JAMES C (Director, Executive Chairman)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2013-10-16	Common Stock	M	300000	$3.00	Acquired	9257422	Indirect

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2013-10-16	Class A-2 Warrant (right to buy)	$3.00	M	300000	Disposed	2014-02-12	Common Stock (300000)	Indirect

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	843450	Direct
Common Stock	179232	Indirect

Footnotes

F1: Reporting Person is a managing member of 10X Capital Management, LLC, a Florida limited liability company acting as the general partner of 10X Fund, L.P., a Delaware limited partnership, and as such, may be deemed to have indirect beneficial ownership of all or a portion of the securities owned directly by 10X Fund, L.P. Mr. Czirr disclaims beneficial ownership of the reported securities except to the extent of his pecuniary interest therein.